Suppr超能文献

肺结核后肺疾病的评估、管理和康复临床标准。

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

机构信息

Respiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, DSI-NRF South African Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.

出版信息

Int J Tuberc Lung Dis. 2021 Oct 1;25(10):797-813. doi: 10.5588/ijtld.21.0425.

Abstract

Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR). A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement). Five clinical standards were defined: Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR. This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD.

摘要

越来越多的证据表明,肺结核后肺部疾病(PTLD)会导致严重的发病率和死亡率。这些临床标准旨在为 PTLD 的评估和管理以及肺康复(PR)的实施提供指导。确定了一组在结核病护理和 PR 领域的全球专家小组;有 62 人参加了德尔菲流程。使用 5 点李克特量表对标准的初始想法进行评分,经过几轮修订后,该文件获得通过(达成 100%一致)。确定了五个临床标准:标准 1,在结核病治疗结束时评估患者是否存在 PTLD(针对儿童和特定环境/情况进行调整);标准 2,识别适合 PR 的 PTLD 患者;标准 3,根据患者需求和当地情况定制 PR 计划;标准 4,评估 PR 的效果;标准 5,开展教育和咨询。标准 6 涉及 PTLD 的公共卫生方面和 PR 导致的结果。这是第一套基于共识的 PTLD 临床标准。我们的目标是通过指导临床医生、项目管理人员和公共卫生官员规划和实施充分的措施来评估和管理 PTLD,从而改善患者的护理和生活质量。

相似文献

4
Clinical standards for drug-susceptible pulmonary TB.耐药结核病临床诊疗指南
Int J Tuberc Lung Dis. 2022 Jul 1;26(7):592-604. doi: 10.5588/ijtld.22.0228.
5
Clinical standards for the dosing and management of TB drugs.结核病药物剂量和管理的临床标准。
Int J Tuberc Lung Dis. 2022 Jun 1;26(6):483-499. doi: 10.5588/ijtld.22.0188.
8
Standards for clinical trials for treating TB.治疗结核病的临床试验标准。
Int J Tuberc Lung Dis. 2023 Dec 1;27(12):885-898. doi: 10.5588/ijtld.23.0341.

引用本文的文献

本文引用的文献

1
The burden and determinants of post-TB lung disease.结核后肺部疾病的负担和决定因素。
Int J Tuberc Lung Dis. 2021 Oct 1;25(10):846-853. doi: 10.5588/ijtld.21.0278.
2
Assessment of TB treatment on patient well-being.结核病治疗对患者健康状况的评估。
Int J Tuberc Lung Dis. 2021 Apr 1;25(4):315-317. doi: 10.5588/ijtld.21.0816.
4
9
Clinical care for patients with post-TB lung disease.肺结核后肺部疾病患者的临床护理。
Int J Tuberc Lung Dis. 2021 Mar 1;25(3):252-253. doi: 10.5588/ijtld.20.0824.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验